122 related articles for article (PubMed ID: 17895548)
1. Effect of intravenous administration of cibenzoline on left ventricular diastolic pressures in patients with hypertrophic cardiomyopathy: its relationship to transmitral Doppler flow profiles.
Hamada M; Aono J; Ikeda S; Watanabe K; Inaba S; Suzuki J; Ohtsuka T; Shigematsu Y
Circ J; 2007 Oct; 71(10):1540-4. PubMed ID: 17895548
[TBL] [Abstract][Full Text] [Related]
2. Effect of cibenzoline, a class ia antiarrhythmic agent, on left ventricular diastolic function in hypertrophic cardiomyopathy.
Kondo I; Mizushige K; Nozaki S; Iwado Y; Masugata H; Kohno M; Matsuo H
Cardiovasc Drugs Ther; 2001 Sep; 15(5):459-65. PubMed ID: 11855665
[TBL] [Abstract][Full Text] [Related]
3. Antiarrhythmic drug cibenzoline attenuates left ventricular pressure gradient and improves transmitral Doppler flow pattern in patients with hypertrophic obstructive cardiomyopathy caused by midventricular obstruction.
Hamada M; Shigematsu Y; Inaba S; Aono J; Ikeda S; Watanabe K; Ogimoto A; Ohtsuka T; Hara Y; Higaki J
Circ J; 2005 Aug; 69(8):940-5. PubMed ID: 16041163
[TBL] [Abstract][Full Text] [Related]
4. Antiarrhythmic drug, cibenzoline, can directly improve the left ventricular diastolic function in patients with hypertrophic cardiomyopathy.
Hamada M; Shigematsu Y; Hara Y; Suzuki M; Ohtsuka T; Hiasa G; Ogimoto A; Saeki H; Suzuki J; Hiwada K
Jpn Circ J; 2001 Jun; 65(6):531-8. PubMed ID: 11407736
[TBL] [Abstract][Full Text] [Related]
5. Impact of chronic use of cibenzoline on left ventricular pressure gradient and left ventricular remodeling in patients with hypertrophic obstructive cardiomyopathy.
Hamada M; Ikeda S; Ohshima K; Nakamura M; Kubota N; Ogimoto A; Shigematsu Y
J Cardiol; 2016 Mar; 67(3):279-86. PubMed ID: 26116980
[TBL] [Abstract][Full Text] [Related]
6. Cibenzoline improves coronary flow velocity reserve in patients with hypertrophic obstructive cardiomyopathy.
Sekine T; Daimon M; Hasegawa R; Teramoto K; Kawata T; Tanaka N; Takei Y; Takazawa K; Yoshida K; Komuro I
Heart Vessels; 2006 Nov; 21(6):350-5. PubMed ID: 17143709
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetic interactions between Angiotensin-converting enzyme insertion/deletion polymorphism and response to cibenzoline in patients with hypertrophic obstructive cardiomyopathy.
Ogimoto A; Okayama H; Nagai T; Ohtsuka T; Suzuki J; Inoue K; Nishimura K; Saito M; Shigematsu Y; Hamada M; Miki T; Higaki J
J Cardiovasc Pharmacol; 2010 May; 55(5):506-10. PubMed ID: 20179607
[TBL] [Abstract][Full Text] [Related]
8. Class Ia antiarrhythmic drug cibenzoline: a new approach to the medical treatment of hypertrophic obstructive cardiomyopathy.
Hamada M; Shigematsu Y; Ikeda S; Hara Y; Okayama H; Kodama K; Ochi T; Hiwada K
Circulation; 1997 Sep; 96(5):1520-4. PubMed ID: 9315541
[TBL] [Abstract][Full Text] [Related]
9. Effect of cibenzoline on regional left ventricular function in hypertrophic obstructive cardiomyopathy.
Kondo I; Mizushige K; Nozaki S; Hirao K; Iwado Y; Ohmori K; Matsuo H
Clin Cardiol; 2000 Sep; 23(9):689-96. PubMed ID: 11016020
[TBL] [Abstract][Full Text] [Related]
10. Comparison of acute reduction in left ventricular outflow tract pressure gradient in obstructive hypertrophic cardiomyopathy by disopyramide versus pilsicainide versus cibenzoline.
Kajimoto K; Imai T; Minami Y; Kasanuki H
Am J Cardiol; 2010 Nov; 106(9):1307-12. PubMed ID: 21029829
[TBL] [Abstract][Full Text] [Related]
11. Myocardial fibrosis attenuates the effect of cibenzoline on left ventricular diastolic function in patients with hypertrophic cardiomyopathy.
Saito M; Okayama H; Yoshii T; Hiasa G; Sumimoto T; Inaba S; Nishimura K; Inoue K; Ogimoto A; Shigematsu Y; Funada J; Hamada M; Higaki J
J Cardiovasc Pharmacol; 2011 Feb; 57(2):207-12. PubMed ID: 21052009
[TBL] [Abstract][Full Text] [Related]
12. Mitral regurgitation disappearance after cibenzoline treatment in a patient with hypertrophic obstructive cardiomyopathy.
Inada K; Komukai K; Mori C; Nagasawa H; Shibata T; Mochizuki S
Intern Med; 2004 Jan; 43(1):55-8. PubMed ID: 14964580
[TBL] [Abstract][Full Text] [Related]
13. Effect of cibenzoline on biventricular pressure gradients in a pediatric patient with hypertrophic obstructive cardiomyopathy.
Ishikawa T; Iwashima S; Ohzeki T
Pediatr Cardiol; 2010 Jul; 31(5):707-10. PubMed ID: 20140606
[TBL] [Abstract][Full Text] [Related]
14. Effect of disopyramide on left ventricular pressure gradient in hypertrophic obstructive cardiomyopathy in comparison with propranolol--a case report.
Tokudome T; Mizushige K; Ueda T; Sakamoto S; Matsuo H
Angiology; 1999 Apr; 50(4):331-5. PubMed ID: 10225470
[TBL] [Abstract][Full Text] [Related]
15. Advances in medical treatment of hypertrophic cardiomyopathy.
Hamada M; Ikeda S; Shigematsu Y
J Cardiol; 2014 Jul; 64(1):1-10. PubMed ID: 24735741
[TBL] [Abstract][Full Text] [Related]
16. Impact of cibenzoline treatment on left ventricular remodelling and prognosis in hypertrophic obstructive cardiomyopathy.
Hamada M; Shigematsu Y; Ikeda S; Ohshima K; Ogimoto A
ESC Heart Fail; 2021 Dec; 8(6):4832-4842. PubMed ID: 34713615
[TBL] [Abstract][Full Text] [Related]
17. [Beneficial effect of cibenzoline in a patient with hypertrophic obstructive cardiomyopathy complicated with idiopathic interstitial pneumonia].
Saito M; Hara Y; Shigematsu Y; Ohtsuka T; Saeki H; Ogimoto A; Yokoyama A; Hamada M
Nihon Ronen Igakkai Zasshi; 2003 Jan; 40(1):62-4. PubMed ID: 12649850
[TBL] [Abstract][Full Text] [Related]
18. Attenuation of biventricular pressure gradients by cibenzo-line in an 18-year-old patient with hypertrophic obstructive cardiomyopathy.
Hiasa G; Hamada M; Shigematsu Y; Hara Y; Ohtsuka T; Ogimoto A; Saeki H; Suzuki J; Matsunaka T; Hamada H; Okura T; Hiwada K
Circ J; 2002 Dec; 66(12):1173-5. PubMed ID: 12499627
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy of cibenzoline for chest oppression and ventricular arrhythmia during effort and alcohol consumption in a patient with hypertrophic obstructive cardiomyopathy: a case report].
Sasayama T; Horimoto M; Takeda T; Takenaka T; Inoue H; Igarashi K; Akino M; Kikuchi K
J Cardiol; 2000 Jun; 35(6):445-50. PubMed ID: 10884982
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of left ventricular filling pressures by Doppler echocardiography in patients with hypertrophic cardiomyopathy: correlation with direct left atrial pressure measurement at cardiac catheterization.
Geske JB; Sorajja P; Nishimura RA; Ommen SR
Circulation; 2007 Dec; 116(23):2702-8. PubMed ID: 18025528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]